Ophthalmology

• 

  Publication Venue For

  • Reply. 2023
  • Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of Ophthalmology. 2022
  • Glaucoma Genetic Risk Scores in the Million Veteran Program..  129:1263-1274. 2022
  • Disparities in Vision Health and Eye Care..  129:e89-e113. 2022
  • Impact of Vision Impairment and Ocular Morbidity and Their Treatment on Depression and Anxiety in Children: A Systematic Review..  129:1152-1170. 2022
  • Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes..  129:1120-1128. 2022
  • MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid..  129:974-985. 2022
  • Myopic Shift at 10-Year Follow-up in the Infant Aphakia Treatment Study..  129:1064-1065. 2022
  • The Pediatric Optic Neuritis Prospective Outcomes Study: Two-Year Results..  129:856-864. 2022
  • Artificial Intelligence for Retinopathy of Prematurity: Validation of a Vascular Severity Scale against International Expert Diagnosis..  129:e69-e76. 2022
  • Iris Heterochromia and Scleral Yellowing Secondary to Self-Injury..  129:791. 2022
  • From Data to Deployment: The Collaborative Community on Ophthalmic Imaging Roadmap for Artificial Intelligence in Age-Related Macular Degeneration..  129:e43-e59. 2022
  • Intravitreal Pharmacotherapies for Diabetic Macular Edema: A Report by the American Academy of Ophthalmology..  129:88-99. 2022
  • Re: Fairless et al.: Ophthalmology departments remain among the least diverse clinical departments at United States medical schools (Ophthalmology. 2021;128:1129-1134)..  129:e7-e8. 2022
  • Reply..  128:e219-e220. 2021
  • Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH..  128:1592-1603. 2021
  • International Classification of Retinopathy of Prematurity, Third Edition..  128:e51-e68. 2021
  • OCT Angiography for the Diagnosis of Glaucoma: A Report by the American Academy of Ophthalmology..  128:1222-1235. 2021
  • Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER..  128:1050-1059. 2021
  • Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis..  128:899-909. 2021
  • Medical Malpractice Lawsuits Involving Ophthalmology Trainees..  128:938-942. 2021
  • Reply..  128:e26-e27. 2021
  • Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results..  128:719-728. 2021
  • C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial..  128:576-586. 2021
  • Detection of Progressive Glaucomatous Optic Nerve Damage on Fundus Photographs with Deep Learning..  128:383-392. 2021
  • Outcomes of Bilateral Cataract Surgery in Infants 7 to 24 Months of Age Using the Toddler Aphakia and Pseudophakia Treatment Study Registry..  128:302-308. 2021
  • Impact of Intraocular Pressure Control on Rates of Retinal Nerve Fiber Layer Loss in a Large Clinical Population..  128:48-57. 2021
  • Primary Angle-Closure Disease Preferred Practice Pattern®..  128:P30-P70. 2021
  • Primary Angle-Closure Disease Preferred Practice Pattern®..  128:P30-P70. 2021
  • Primary Open-Angle Glaucoma Preferred Practice Pattern®..  128:P71-P150. 2021
  • Primary Open-Angle Glaucoma Preferred Practice Pattern®..  128:P71-P150. 2021
  • Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern®..  128:P151-P192. 2021
  • Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern®..  128:P151-P192. 2021
  • Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)..  127:1627-1641. 2020
  • Complications at 10 Years of Follow-up in the Infant Aphakia Treatment Study..  127:1581-1583. 2020
  • Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma..  127:1549-1557. 2020
  • Using Deep Learning to Automate Goldmann Applanation Tonometry Readings..  127:1498-1506. 2020
  • Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results..  127:1395-1404. 2020
  • Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016..  127:1292-1302. 2020
  • Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab..  127:1345-1359. 2020
  • Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)..  127:1201-1210. 2020
  • Intraocular Lens Implantation in the Absence of Zonular Support: An Outcomes and Safety Update: A Report by the American Academy of Ophthalmology..  127:1234-1258. 2020
  • Re: Flaxel et al.: Retinal and ophthalmic artery occlusions Preferred Practice Pattern® (Ophthalmology. 2020;127:P259-P287)..  127:e59-e60. 2020
  • Lighting a Pathway: The Minority Ophthalmology Mentoring Program..  127:848-851. 2020
  • Anti-Vascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration: Systematic Literature Review and Expert Opinion..  127:648-659. 2020
  • Comparing the Management of Eye Injuries by Coalition Military Surgeons during the Iraq and Afghanistan Conflicts..  127:458-466. 2020
  • Outcomes of Bilateral Cataracts Removed in Infants 1 to 7 Months of Age Using the Toddler Aphakia and Pseudophakia Treatment Study Registry..  127:501-510. 2020
  • Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results..  127:S135-S145. 2020
  • Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4..  127:394-409. 2020
  • Adult Strabismus Preferred Practice Pattern®..  127:P182-P298. 2020
  • Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology..  127:128-133. 2020
  • HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration..  127:72-84. 2020
  • Assessment of Macular Microvasculature in Healthy Eyes of Infants and Children Using OCT Angiography..  126:1703-1711. 2019
  • Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure..  126:1640-1646. 2019
  • Deep Learning and Glaucoma Specialists: The Relative Importance of Optic Disc Features to Predict Glaucoma Referral in Fundus Photographs..  126:1627-1639. 2019
  • Does Aspirin Worsen Macular Degeneration in a Clinically Meaningful Way?.  126:1657-1658. 2019
  • Reply..  126:e96-e97. 2019
  • Autologous Retinal Transplant for Refractory Macular Holes: Multicenter International Collaborative Study Group..  126:1399-1408. 2019
  • Rhegmatogenous Retinal Detachment after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor..  126:1424-1431. 2019
  • Outcomes of Unilateral Cataracts in Infants and Toddlers 7 to 24 Months of Age: Toddler Aphakia and Pseudophakia Study (TAPS)..  126:1189-1195. 2019
  • Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series..  126:1058-1062. 2019
  • Acute Angle Closure Glaucoma in Von Hippel-Lindau Syndrome..  126:691. 2019
  • Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials..  126:743-751. 2019
  • Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study..  126:702-711. 2019
  • Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial..  126:540-549. 2019
  • Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results..  126:601-610. 2019
  • From Machine to Machine: An OCT-Trained Deep Learning Algorithm for Objective Quantification of Glaucomatous Damage in Fundus Photographs..  126:513-521. 2019
  • Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis..  126:497-510. 2019
  • The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology..  126:611-622. 2019
  • Eight-Year Incidence of Open-Angle Glaucoma in the Tema Eye Survey..  126:372-380. 2019
  • Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor..  126:407-413. 2019
  • A Randomized Trial Comparing Bilateral Lateral Rectus Recession versus Unilateral Recess and Resect for Basic-Type Intermittent Exotropia..  126:305-317. 2019
  • Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17..  126:261-273. 2019
  • Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial..  126:283-295. 2019
  • Association between Rates of Visual Field Progression and Intraocular Pressure Measurements Obtained by Different Tonometers..  126:49-54. 2019
  • Choosing Core Outcomes for Use in Clinical Trials in Ophthalmology: Perspectives from Three Ophthalmology Outcomes Working Groups..  126:6-9. 2019
  • Genetic Architecture of Primary Open-Angle Glaucoma in Individuals of African Descent: The African Descent and Glaucoma Evaluation Study III..  126:38-48. 2019
  • Re: Nudleman et al.: Glaucoma after lens-sparing vitrectomy for advanced retinopathy of prematurity (Ophthalmology. 2018;125:671-675)..  126:e4. 2019
  • Sexual Harassment in Ophthalmology: A Survey Study..  126:172-174. 2019
  • The African Descent and Glaucoma Evaluation Study (ADAGES) III: Contribution of Genotype to Glaucoma Phenotype in African Americans: Study Design and Baseline Data..  126:156-170. 2019
  • Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16..  125:1913-1928. 2018
  • Six-Year Incidence of and Risk Factors for Cataract Surgery in a Multi-ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study..  125:1844-1853. 2018
  • The Relationship of Retinal Vessel Geometric Characteristics to the Incidence and Progression of Diabetic Retinopathy..  125:1784-1792. 2018
  • Reply..  125:e69-e70. 2018
  • Impact of Incidence and Progression of Diabetic Retinopathy on Vision-Specific Functioning..  125:1401-1409. 2018
  • Reply..  125:e63. 2018
  • Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials..  125:1037-1046. 2018
  • Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema..  125:1054-1063. 2018
  • Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III..  125:1075-1087. 2018
  • Reply..  125:e42. 2018
  • Choroidal Nevi in the Singapore Epidemiology of Eye Disease Study..  125:784-786. 2018
  • Evaluation of Primary Angle-Closure Glaucoma Susceptibility Loci in Patients with Early Stages of Angle-Closure Disease..  125:664-670. 2018
  • Nonsyndromic Retinitis Pigmentosa in the Ashkenazi Jewish Population: Genetic and Clinical Aspects..  125:725-734. 2018
  • Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management..  125:708-724. 2018
  • Review of Ophthalmology Medical Professional Liability Claims in the United States from 2006 through 2015..  125:631-641. 2018
  • Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3..  125:537-548. 2018
  • Establishing a Vision and Eye Health Surveillance System for the Nation: A Status Update on the Vision and Eye Health Surveillance System..  125:471-473. 2018
  • Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs..  125:332-339. 2018
  • Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study..  125:391-397. 2018
  • Reply..  125:e24. 2018
  • Clinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer..  125:318-320. 2018
  • Descemet Membrane Endothelial Keratoplasty: Safety and Outcomes: A Report by the American Academy of Ophthalmology..  125:295-310. 2018
  • Predicting Vision-Related Disability in Glaucoma..  125:22-30. 2018
  • Reply..  125:e9-e10. 2018
  • Reply..  125:e11-e12. 2018
  • Reply..  125:e4-e6. 2018
  • The Effect of Testing Reliability on Visual Field Sensitivity in Normal Eyes: The Singapore Chinese Eye Study..  125:15-21. 2018
  • Detecting Structural Progression in Glaucoma with Optical Coherence Tomography..  124:S57-S65. 2017
  • Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management..  124:1690-1711. 2017
  • 24-2 Visual Fields Miss Central Defects Shown on 10-2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma..  124:1449-1456. 2017
  • Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma..  124:1532-1539. 2017
  • Impact of Total Pars Plana Vitrectomy on Postoperative Complications in Aphakic, Snap-On, Type 1 Boston Keratoprosthesis..  124:1504-1509. 2017
  • Large Disparities in Receipt of Glaucoma Care between Enrollees in Medicaid and Those with Commercial Health Insurance..  124:1442-1448. 2017
  • Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial..  124:1296-1304. 2017
  • Comparison of Corneal Biomechanical Properties between Indian and Chinese Adults..  124:1271-1279. 2017
  • Comparison of Visual Outcomes in Coats' Disease: A 20-Year Experience..  124:1368-1376. 2017
  • Therapies for Macular Edema Associated with Branch Retinal Vein Occlusion: A Report by the American Academy of Ophthalmology..  124:1412-1423. 2017
  • Reply..  124:e62-e63. 2017
  • Anterior Chamber Angle Invasion of Iridociliary Melanoma..  124:842. 2017
  • Frequency of Testing to Detect Visual Field Progression Derived Using a Longitudinal Cohort of Glaucoma Patients..  124:786-792. 2017
  • Myopic Shift 5 Years after Intraocular Lens Implantation in the Infant Aphakia Treatment Study..  124:822-827. 2017
  • Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies..  124:776-785. 2017
  • Peripapillary and Macular Vessel Density in Patients with Glaucoma and Single-Hemifield Visual Field Defect..  124:709-719. 2017
  • Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings..  124:464-478. 2017
  • Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group..  124:479-487. 2017
  • Reply..  124:e45. 2017
  • Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology..  124:382-392. 2017
  • Reply..  124:e25. 2017
  • Type 2 Diabetes Genetic Variants and Risk of Diabetic Retinopathy..  124:336-342. 2017
  • Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration: A Phase IIb, Multicenter, Randomized Controlled Trial..  124:224-234. 2017
  • Reply..  124:e19. 2017
  • Reply..  124:e21. 2017
  • Vision and Public Health: Framing a Purpose for Our Work..  124:148-150. 2017
  • Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials..  124:97-104. 2017
  • Cataract Surgery in Children from Birth to Less than 13 Years of Age: Baseline Characteristics of the Cohort..  123:2462-2473. 2016
  • Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore..  123:2571-2580. 2016
  • Deep Retinal Layer Microvasculature Dropout Detected by the Optical Coherence Tomography Angiography in Glaucoma..  123:2509-2518. 2016
  • Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration..  123:2554-2570. 2016
  • Relationship between Optical Coherence Tomography Angiography Vessel Density and Severity of Visual Field Loss in Glaucoma..  123:2498-2508. 2016
  • Optical Coherence Tomography Angiography Vessel Density in Glaucomatous Eyes with Focal Lamina Cribrosa Defects..  123:2309-2317. 2016
  • Pediatric Idiopathic Intracranial Hypertension: Age, Gender, and Anthropometric Features at Diagnosis in a Large, Retrospective, Multisite Cohort..  123:2424-2431. 2016
  • Visual Impairment in Old and Very Old Community-dwelling Asian Adults..  123:2436-2438. 2016
  • Iris Crypts Influence Dynamic Changes of Iris Volume..  123:2077-2084. 2016
  • Assessing Geographic Variation in Strabismus Diagnosis among Children Enrolled in Medicaid..  123:2013-2022. 2016
  • Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid..  123:1856-1864. 2016
  • Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results..  123:1940-1948. 2016
  • Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials..  123:1751-1761. 2016
  • Intraocular Pressure Reduction after Phacoemulsification versus Manual Small-Incision Cataract Surgery: A Randomized Controlled Trial..  123:1695-1703. 2016
  • African Descent and Glaucoma Evaluation Study (ADAGES): Racial Differences in Optic Disc Hemorrhage and Beta-Zone Parapapillary Atrophy..  123:1476-1483. 2016
  • Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials..  123:1521-1529. 2016
  • Incidence of Age-Related Macular Degeneration in a Multi-Ethnic United States Population: The Multi-Ethnic Study of Atherosclerosis..  123:1297-1308. 2016
  • Structure versus Function in Glaucoma: The Debate That Doesn't Need to Be..  123:1170-1172. 2016
  • Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050..  123:1036-1042. 2016
  • A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema..  123:841-849. 2016
  • Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials..  123:858-864. 2016
  • Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma..  123:754-759. 2016
  • Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials..  123:865-875. 2016
  • Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes..  123:760-770. 2016
  • Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)..  123:609-616. 2016
  • Rates of Vitrectomy among Enrollees in a United States Managed Care Network, 2001-2012..  123:590-598. 2016
  • The Impact of Location of Progressive Visual Field Loss on Longitudinal Changes in Quality of Life of Patients with Glaucoma..  123:552-557. 2016
  • Diagnostic Accuracy of the Spectralis and Cirrus Reference Databases in Differentiating between Healthy and Early Glaucoma Eyes..  123:408-414. 2016
  • Evaluation of Screening for Retinopathy of Prematurity by ROPtool or a Lay Reader..  123:385-390. 2016
  • Natural History of Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration (Geographic Atrophy Progression Study)..  123:361-368. 2016
  • Reply..  123:e17-e18. 2016
  • A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration..  123:78-85. 2016
  • Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis..  123:129-140. 2016
  • Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration..  123:39-50.e1. 2016
  • Primary Angle Closure Preferred Practice Pattern(®) Guidelines..  123:P1-P40. 2016
  • Primary Open-Angle Glaucoma Preferred Practice Pattern(®) Guidelines..  123:P41-P111. 2016
  • Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern(®) Guidelines..  123:P112-P151. 2016
  • Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT)..  122:2523-31.e1. 2015
  • Evidence in Ophthalmology: Are We Doing Better?.  122:2584-2586. 2015
  • Ancestry, Socioeconomic Status, and Age-Related Cataract in Asians: The Singapore Epidemiology of Eye Diseases Study..  122:2169-2178. 2015
  • Corneal Changes in Children after Unilateral Cataract Surgery in the Infant Aphakia Treatment Study..  122:2186-2192. 2015
  • MMP20 and ARMS2/HTRA1 Are Associated with Neovascular Lesion Size in Age-Related Macular Degeneration..  122:2295-2302.e2. 2015
  • Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results..  122:2351-2359. 2015
  • Rates of Retinal Nerve Fiber Layer Loss in Contralateral Eyes of Glaucoma Patients with Unilateral Progression by Conventional Methods..  122:2243-2251. 2015
  • Estimating Lead Time Gained by Optical Coherence Tomography in Detecting Glaucoma before Development of Visual Field Defects..  122:2002-2009. 2015
  • Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up..  122:2010-2021. 2015
  • Re: Saksens et al.: Dominant cystoid macular dystrophy (Ophthalmology 2015;122:180-91)..  122:e59-e60. 2015
  • Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials..  122:1846-53.e5. 2015
  • The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey..  122:1308-1316. 2015
  • Aggregate Effects of Intraocular Pressure and Cup-to-Disc Ratio Genetic Variants on Glaucoma in a Multiethnic Asian Population..  122:1149-1157. 2015
  • Association between Smoking and Uveitis: Results from the Pacific Ocular Inflammation Study..  122:1257-1261. 2015
  • Evaluation of Postural Control in Patients with Glaucoma Using a Virtual Reality Environment..  122:1131-1138. 2015
  • Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials..  122:1203-1211. 2015
  • Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization: The MYRROR Study..  122:1220-1227. 2015
  • Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence..  122:748-754. 2015
  • Optical coherence tomography accurately measures corneal power change from laser refractive surgery..  122:677-686. 2015
  • Author reply: To PMID 24393349..  122:e19. 2015
  • Glaucoma and associated visual acuity and field loss significantly affect glaucoma-specific psychosocial functioning..  122:494-501. 2015
  • Poorer neurodevelopmental outcomes associated with cystoid macular edema identified in preterm infants in the intensive care nursery..  122:610-619. 2015
  • Retinal nerve fiber layer thickness measurements: uveitis, a major confounding factor..  122:511-517. 2015
  • Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results..  122:375-381. 2015
  • Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients..  122:293-301. 2015
  • Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)..  122:391-398.e5. 2015
  • Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials..  122:117-122. 2015
  • Relationship between ganglion cell layer thickness and estimated retinal ganglion cell counts in the glaucomatous macula..  121:2371-2379. 2014
  • Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis..  121:2081-2090. 2014
  • Intravitreal aflibercept for diabetic macular edema..  121:2247-2254. 2014
  • Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials..  121:1956-1965. 2014
  • Ethnic differences of intraocular pressure and central corneal thickness: the Singapore Epidemiology of Eye Diseases study..  121:2013-2022. 2014
  • Evaluation of optic nerve development in preterm and term infants using handheld spectral-domain optical coherence tomography..  121:1818-1826. 2014
  • Health burden associated with visual impairment in Singapore: the Singapore epidemiology of eye disease study..  121:1837-1842. 2014
  • Prevalence, racial variations, and risk factors of age-related macular degeneration in Singaporean Chinese, Indians, and Malays..  121:1598-1603. 2014
  • Adult ophthalmology inpatient consults at a tertiary care teaching hospital..  121:1489-91.e1. 2014
  • Rates of retinal nerve fiber layer thinning in glaucoma suspect eyes..  121:1350-1358. 2014
  • Use of statistical analyses in the ophthalmic literature..  121:1317-1321. 2014
  • Detecting glaucoma using automated pupillography..  121:1185-1193. 2014
  • Three-dimensional assessment of vascular and perivascular characteristics in subjects with retinopathy of prematurity..  121:1289-1296. 2014
  • Assessment of iris surface features and their relationship with iris thickness in Asian eyes..  121:1007-1012. 2014
  • Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials..  121:1102-1108. 2014
  • The use of Bowman's layer vertical topographic thickness map in the diagnosis of keratoconus..  121:988-993. 2014
  • Use of health care claims data to study patients with ophthalmologic conditions..  121:1134-1141. 2014
  • Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration..  121:936-945. 2014
  • RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia..  121:682-92.e2. 2014
  • Association of CAV1/CAV2 genomic variants with primary open-angle glaucoma overall and by gender and pattern of visual field loss..  121:508-516. 2014
  • Predicting progression of glaucoma from rates of frequency doubling technology perimetry change..  121:498-507. 2014
  • Defects of the lamina cribrosa in eyes with localized retinal nerve fiber layer loss..  121:110-118. 2014
  • Evaluation of progressive neuroretinal rim loss as a surrogate end point for development of visual field loss in glaucoma..  121:100-109. 2014
  • Performance of the Moorfields motion displacement test for identifying eyes with glaucoma..  121:88-92. 2014
  • Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography..  121:162-172. 2014
  • Assessment of choroidal thickness and volume during the water drinking test by swept-source optical coherence tomography..  120:2508-2516. 2013
  • Author reply: To PMID 23642371..  120:e85-e86. 2013
  • Resident compliance with the american academy of ophthalmology preferred practice pattern guidelines for primary open-angle glaucoma..  120:2462-2469. 2013
  • Refractive errors and age-related macular degeneration: a systematic review and meta-analysis..  120:2058-2065. 2013
  • Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials..  120:1860-1870. 2013
  • Corneal hysteresis as a risk factor for glaucoma progression: a prospective longitudinal study..  120:1533-1540. 2013
  • Streptococcal endophthalmitis in pediatric keratoprosthesis..  120:1506-7.e1. 2013
  • Aflibercept-related sterile inflammation..  120:1100-101.e1-5. 2013
  • Diagnosis of ocular surface lesions using ultra-high-resolution optical coherence tomography..  120:883-891. 2013
  • Neuro-ophthalmology Safer Than MRI?.  120:879. 2013
  • Retinal ganglion cell count estimates associated with early development of visual field defects in glaucoma..  120:736-744. 2013
  • Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study..  120:451-456. 2013
  • Differential associations of myopia with major age-related eye diseases: the Singapore Indian Eye Study..  120:284-291. 2013
  • Genetic association of refractive error and axial length with 15q14 but not 15q25 in the Blue Mountains Eye Study cohort..  120:292-297. 2013
  • Vision impairment and major causes of vision loss impacts on vision-specific functioning independent of socioeconomic factors..  120:415-422. 2013
  • Classification algorithms based on anterior segment optical coherence tomography measurements for detection of angle closure..  120:48-54. 2013
  • Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab..  120:160-168. 2013
  • Retinal vascular geometry and glaucoma: the Singapore Malay Eye Study..  120:77-83. 2013
  • Retinal vessel caliber is associated with the 10-year incidence of glaucoma: the Blue Mountains Eye Study..  120:84-90. 2013
  • Determinants of retinal venular diameter: the Beaver Dam Eye Study..  119:2563-2571. 2012
  • Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials..  119:2549-2557. 2012
  • Diagnosing preperimetric glaucoma with spectral domain optical coherence tomography..  119:2261-2269. 2012
  • Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials..  119:2108-2118. 2012
  • Prevalence and risk factors of diabetic retinopathy in migrant Indians in an urbanized society in Asia: the Singapore Indian eye study..  119:2119-2124. 2012
  • Blindness and visual impairment in an urban West African population: the Tema Eye Survey..  119:1744-1753. 2012
  • Longer axial length is protective of diabetic retinopathy and macular edema..  119:1754-1759. 2012
  • Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma..  119:1596-1603. 2012
  • Prevalence of and racial differences in pterygium: a multiethnic population study in Asians..  119:1509-1515. 2012
  • Congenital ectropion uvea and mechanisms of glaucoma in neurofibromatosis type 1: new insights..  119:1485-1494. 2012
  • Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results..  119:1388-1398. 2012
  • The development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model..  119:1367-1374. 2012
  • Determinants of anterior chamber depth: the Singapore Chinese Eye Study..  119:1143-1150. 2012
  • Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant..  119:1190-1198. 2012
  • HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration..  119:1175-1183. 2012
  • Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis..  119:765-770. 2012
  • Vitrectomy without laser treatment or gas tamponade for macular detachment associated with an optic disc pit..  119:810-818. 2012
  • Congenital fibrovascular pupillary membranes: clinical and histopathologic findings..  119:634-641. 2012
  • Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma..  119:468-473. 2012
  • Integrating event- and trend-based analyses to improve detection of glaucomatous visual field progression..  119:458-467. 2012
  • Is corneal thickness an independent risk factor for glaucoma?.  119:435-436. 2012
  • Determinants of angle width in Chinese Singaporeans..  119:278-282. 2012
  • Amblyopia prevalence and risk factors in Australian preschool children..  119:138-144. 2012
  • Clinical characteristics in 53 patients with cat scratch optic neuropathy..  119:183-187. 2012
  • Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results..  119:132-137. 2012
  • Complications, adverse events, and additional intraocular surgery 1 year after cataract surgery in the infant Aphakia Treatment Study..  118:2330-2334. 2011
  • Dynamics of human foveal development after premature birth..  118:2315-2325. 2011
  • Prevalence and characteristics of choroidal nevi: the multi-ethnic study of atherosclerosis..  118:2468-2473. 2011
  • Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema..  118:e5-14. 2011
  • The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity..  118:2398-2402. 2011
  • Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study..  118:2014-2021. 2011
  • Latanoprost systemic exposure in pediatric and adult patients with glaucoma: a phase 1, open-label study..  118:2022-2027. 2011
  • Myopia-related optic disc and retinal changes in adolescent children from singapore..  118:2050-2057. 2011
  • Prevalence and causes of visual impairment and blindness in an urban Indian population: the Singapore Indian Eye Study..  118:1798-1804. 2011
  • Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography..  118:1531-1537. 2011
  • Prevalence and risk factors for visual impairment in preschool children the sydney paediatric eye disease study..  118:1495-1500. 2011
  • Ten-year longitudinal changes in retinal microvascular lesions: the atherosclerosis risk in communities study..  118:1612-1618. 2011
  • Comparison of the diagnostic accuracies of the Spectralis, Cirrus, and RTVue optical coherence tomography devices in glaucoma..  118:1334-1339. 2011
  • Determinants of corneal biomechanical properties in an adult Chinese population..  118:1253-1259. 2011
  • Influence of blood pressure on retinal vascular caliber in young children..  118:1459-1465. 2011
  • Prevalence of age-related macular degeneration in a rural Chinese population: the Handan Eye Study..  118:1395-1401. 2011
  • Ultra high-resolution anterior segment optical coherence tomography in the evaluation of anterior corneal dystrophies and degenerations..  118:1291-1296. 2011
  • A critical appraisal and comparison of the quality and recommendations of glaucoma clinical practice guidelines..  118:1017-1023. 2011
  • Optimizing diagnosis and management of nocardia keratitis, scleritis, and endophthalmitis: 11-year microbial and clinical overview..  118:1193-1200. 2011
  • Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial..  118:866-872. 2011
  • Is diabetic retinopathy related to subclinical cardiovascular disease?.  118:860-865. 2011
  • Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons..  118:846-852. 2011
  • Retinal vascular tortuosity, blood pressure, and cardiovascular risk factors..  118:812-818. 2011
  • Prevalence and risk factors for epiretinal membranes in a multi-ethnic United States population..  118:694-699. 2011
  • Retinopathy signs in people without diabetes: the multi-ethnic study of atherosclerosis..  118:656-662. 2011
  • Lens vault, thickness, and position in Chinese subjects with angle closure..  118:474-479. 2011
  • The heritability and sibling risk of angle closure in Asians..  118:480-485. 2011
  • Genome-wide association studies reveal genetic variants in CTNND2 for high myopia in Singapore Chinese..  118:368-375. 2011
  • Prevalence and causes of amblyopia in a rural adult population of Chinese the Handan Eye Study..  118:279-283. 2011
  • Interobserver agreement and intraobserver reproducibility of the subjective determination of glaucomatous visual field progression..  118:60-65. 2011
  • Reversal of retinal ganglion cell dysfunction after surgical reduction of intraocular pressure..  117:2329-2336. 2010
  • Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure..  117:2075-2079. 2010
  • The relationship between intraocular pressure reduction and rates of progressive visual field loss in eyes with optic disc hemorrhage..  117:2061-2066. 2010
  • Vitrectomy for diabetic macular edema..  117:2235-2236. 2010
  • Determinants of agreement between the confocal scanning laser tomograph and standardized assessment of glaucomatous progression..  117:1953-1959. 2010
  • Novel association of smaller anterior chamber width with angle closure in Singaporeans..  117:1967-1973. 2010
  • Comparison of different spectral domain optical coherence tomography scanning areas for glaucoma diagnosis..  117:1692-1699.e1. 2010
  • Diagnostic accuracy of the Heidelberg Retina Tomograph for glaucoma a population-based assessment..  117:1667-1673. 2010
  • The effect of alpha1-adrenergic receptor antagonist tamsulosin (Flomax) on iris dilator smooth muscle anatomy..  117:1743-1749. 2010
  • Assessment of risk factors for infantile cataracts using a case-control study: National Birth Defects Prevention Study, 2000-2004..  117:1500-1505. 2010
  • Normal macular thickness measurements using optical coherence tomography in healthy eyes of adult Chinese persons: the Handan Eye Study..  117:1585-1594. 2010
  • Retinal vascular fractals and microvascular and macrovascular complications in type 1 diabetes..  117:1400-1405. 2010
  • Evaluation of artifacts associated with macular spectral-domain optical coherence tomography..  117:1177-1189.e4. 2010
  • Natural history of branch retinal vein occlusion: an evidence-based systematic review..  117:1094-1101.e5. 2010
  • Natural history of central retinal vein occlusion: an evidence-based systematic review..  117:1113-1123.e15. 2010
  • Use of ultra-high-resolution optical coherence tomography to detect in vivo characteristics of Descemet's membrane in Fuchs' dystrophy..  117:1220-1227. 2010
  • Dietary factors, myopia, and axial dimensions in children..  117:993-997.e4. 2010
  • Hepatocyte growth factor and retinal arteriolar diameter in Singapore Chinese..  117:939-945. 2010
  • The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis..  117:921-927. 2010
  • Impact of diabetic retinopathy on vision-specific function..  117:757-765. 2010
  • Visual field progression..  117:851-852. 2010
  • Agreement for detecting glaucoma progression with the GDx guided progression analysis, automated perimetry, and optic disc photography..  117:462-470. 2010
  • Are myopic eyes less likely to have diabetic retinopathy?.  117:524-530. 2010
  • Chronic kidney disease and intraocular pressure: the Singapore Malay Eye Study..  117:477-483. 2010
  • Distribution of axial length and ocular biometry measured using partial coherence laser interferometry (IOL Master) in an older white population..  117:417-423. 2010
  • Retinopathy in persons without diabetes: the Handan Eye Study..  117:531-537.e2. 2010
  • Diagnostic ability of Heidelberg Retina Tomography in detecting glaucoma in a population setting: the Singapore Malay Eye Study..  117:290-297. 2010
  • Reticular pseudodrusen are subretinal drusenoid deposits..  117:303-12.e1. 2010
  • The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia..  117:313-9.e1. 2010
  • Quantitative iris parameters and association with narrow angles..  117:11-17. 2010
  • Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging..  116:2448-2456. 2009
  • Major eye diseases and risk factors associated with systemic hypertension in an adult Chinese population: the Beijing Eye Study..  116:2373-2380. 2009
  • A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration..  116:2141-8.e1. 2009
  • Refractive errors in a rural Chinese adult population the Handan eye study..  116:2119-2127. 2009
  • Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study..  116:1913-1919. 2009
  • Macular and nerve fiber layer thickness in amblyopia: the Sydney Childhood Eye Study..  116:1604-1609. 2009
  • Outcomes of surgical bleb revision for complications of trabeculectomy..  116:1713-1718. 2009
  • SCORE Study report 3: study design and baseline characteristics..  116:1770-1777.e1. 2009
  • Spectral domain optical coherence tomography imaging of geographic atrophy margins..  116:1762-1769. 2009
  • Correlation of nuclear cataract lens density using Scheimpflug images with Lens Opacities Classification System III and visual function..  116:1436-1443. 2009
  • Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression..  116:1515-1521.e3. 2009
  • Periocular triamcinolone for prevention of macular edema after plaque radiotherapy of uveal melanoma: a randomized controlled trial..  116:1383-1390. 2009
  • The Relationship between intraocular pressure and progressive retinal nerve fiber layer loss in glaucoma..  116:1125-33.e1-3. 2009
  • Relationship of the 24-hour pattern of intraocular pressure with optic disc appearance in primary open-angle glaucoma..  116:833-839. 2009
  • The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States..  116:823-832. 2009
  • Histopathologic examination of failed grafts in descemet's stripping with automated endothelial keratoplasty..  116:603-608. 2009
  • Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy..  116:449-454. 2009
  • Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography..  116:488-496.e2. 2009
  • Prevalence of diabetic retinopathy in rural China: the Handan Eye Study..  116:461-467. 2009
  • Retinal vascular caliber and macular telangiectasia type 2..  116:319-323. 2009
  • Aspirin and dry eye?.  116:167-167.e1. 2009
  • Clinicians agreement in establishing glaucomatous progression using the Heidelberg retina tomograph..  116:14-24. 2009
  • Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study..  115:2141-2145.e2. 2008
  • Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration..  115:1911-1915. 2008
  • Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration..  115:1883-1890. 2008
  • Night vision symptoms and progression of age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial..  115:1876-1882. 2008
  • Prevalence and causes of low vision and blindness in a rural chinese adult population: the Handan Eye Study..  115:1965-1972. 2008
  • Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study..  115:1869-1875. 2008
  • The retinal vasculature as a fractal: methodology, reliability, and relationship to blood pressure..  115:1951-1956. 2008
  • Vision impairment, ocular conditions, and vision-specific function: the Singapore Malay Eye Study..  115:1973-1981. 2008
  • Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis..  115:1742-1749. 2008
  • Prevalence and risk factors for refractive errors in the Singapore Malay Eye Survey..  115:1713-1719. 2008
  • Prevalence of age-related macular degeneration in a Malay population: the Singapore Malay Eye Study..  115:1735-1741. 2008
  • Screening for narrow angles in the singapore population: evaluation of new noncontact screening methods..  115:1720-1727.e2. 2008
  • Understanding the physician's "product" in today's marketplace: improving patient-centered care..  115:1645-1646. 2008
  • Comparison of retinal nerve fiber layer and optic disc imaging for diagnosing glaucoma in patients suspected of having the disease..  115:1340-1346. 2008
  • Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema..  115:1366-1371.e1. 2008
  • Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study..  115:1376-1381.e2. 2008
  • Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002..  115:1315-1319.e1. 2008
  • Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among medicare beneficiaries 1994 to 2005..  115:1109-1116.e7. 2008
  • Diabetes, hyperglycemia, and central corneal thickness: the Singapore Malay Eye Study..  115:964-968.e1. 2008
  • Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma..  115:934-940. 2008
  • Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial..  115:1079-1082.e5. 2008
  • Body mass index and vein occlusion..  115:917-918. 2008
  • Visual acuity and mortality in a chinese population. The Tanjong Pagar Study..  115:802-807. 2008
  • Multivitamin supplements and cataract prevention..  115:597-598. 2008
  • Use of a standardized patient satisfaction questionnaire to assess the quality of care provided by ophthalmology residents..  115:738-743.e3. 2008
  • Peripheral reticular pigmentary change is associated with complement factor H polymorphism (Y402H) in age-related macular degeneration..  115:520-524. 2008
  • The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema..  115:533-539.e2. 2008
  • Ulcerative keratitis in gastrointestinal stromal tumor patients treated with perifosine..  115:483-487. 2008
  • The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis..  115:116-126. 2008
  • Optical coherence tomography of choroidal osteoma in 22 cases: evidence for photoreceptor atrophy over the decalcified portion of the tumor..  114:e53-e58. 2007
  • Adverse events after intravitreal triamcinolone in patients with and without uveitis..  114:1912-1918. 2007
  • Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy..  114:1884-1892. 2007
  • Small choroidal melanoma with chromosome 3 monosomy on fine-needle aspiration biopsy..  114:1919-1924. 2007
  • Vitrectomy for the diagnosis and management of uveitis of unknown cause..  114:1893-1897. 2007
  • Macular degeneration and heart disease..  114:1793. 2007
  • Cost of patients with primary open-angle glaucoma: a retrospective study of commercial insurance claims data..  114:1241-1247. 2007
  • Retinal nerve fiber layer thickness and visual sensitivity using scanning laser polarimetry with variable and enhanced corneal compensation..  114:1259-1265. 2007
  • Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration..  114:1151-1156. 2007
  • Interventions for branch retinal vein occlusion: an evidence-based systematic review..  114:835-854. 2007
  • The value of regular examinations to detect glaucoma and other chronic conditions among older Americans..  114:833-834. 2007
  • Comparison of dynamic contour tonometry and goldmann applanation tonometry in African American subjects..  114:658-665. 2007
  • Interventions for central retinal vein occlusion: an evidence-based systematic review..  114:507-524. 2007
  • Patient outcomes and cataract surgery volume..  114:403-404. 2007
  • Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts..  114:520-524. 2007
  • Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration..  114:246-252. 2007
  • Evaluation of macular thickness measurements for detection of band atrophy of the optic nerve using optical coherence tomography..  114:175-181. 2007
  • Into the looking glass: factors and opportunities to reshape eye care in the next 25 years..  114:1-2. 2007
  • Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation..  113:2317-2323. 2006
  • Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial..  113:1974-1986. 2006
  • Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application..  113:1713-1719. 2006
  • Combining structural and functional testing for detection of glaucoma..  113:1593-1602. 2006
  • Complement factor H increases risk for atrophic age-related macular degeneration..  113:1504-1507. 2006
  • Optical coherence tomography of retinal astrocytic hamartoma in 15 cases..  113:1553-1557. 2006
  • Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes..  113:1499-1503. 2006
  • Retinal vascular caliber in persons with type 2 diabetes: the Wisconsin Epidemiological Study of Diabetic Retinopathy: XX..  113:1488-1498. 2006
  • Cardiovascular risk factors and retinal microvascular signs in an adult Japanese population: the Funagata Study..  113:1378-1384. 2006
  • Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study..  113:1020-1027. 2006
  • Intereye concordance in locations of visual field defects in primary open-angle glaucoma: diagnostic innovations in glaucoma study..  113:918-923. 2006
  • Photoreceptor loss overlying congenital hypertrophy of the retinal pigment epithelium by optical coherence tomography..  113:661-665. 2006
  • Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study..  113:633.e1-633.e4. 2006
  • Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis..  113:373-380. 2006
  • Comparison of 2D reconstructions of surgically excised subfoveal choroidal neovascularization with fluorescein angiographic features: SST report No. 15..  113:279.e1-279.e5. 2006
  • Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort..  113:307.e1. 2006
  • Extraocular muscle surgery for extorsion after macular translocation surgery new surgical technique and clinical management..  113:63-69. 2006
  • Agreement among 3 optical imaging methods for the assessment of optic disc topography..  112:2149-2156. 2005
  • Diffuse unilateral subacute neuroretinitis in Venezuela..  112:2110-2114. 2005
  • Bimatoprost..  112:1478. 2005
  • Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis..  112:1192-1198. 2005
  • Ocular conditions associated with peripapillary subretinal neovascularization, their relative frequencies, and associated outcomes..  112:1054-1061. 2005
  • Endophthalmitis in an Asian population..  112:944. 2005
  • Diagnostic methods for macular edema..  112:734-735. 2005
  • Hypothyroidism and open-angle glaucoma..  112:733. 2005
  • Pediatric optic nerve sheath decompression..  112:724-727. 2005
  • Relationship between central corneal thickness and retinal nerve fiber layer thickness in ocular hypertensive patients..  112:251-256. 2005
  • Retinal vessel diameter and open-angle glaucoma: the Blue Mountains Eye Study..  112:245-250. 2005
  • Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration..  112:144-151. 2005
  • Vision-related quality of life in patients with bilateral severe age-related macular degeneration..  112:152-158. 2005
  • Central corneal thickness and its relationship to intraocular pressure in children..  111:2220-2223. 2004
  • Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration..  111:1715-1724. 2004
  • Hypothyroidism and the development of open-angle glaucoma in a male population..  111:1649-1652. 2004
  • Reply..  123:e6-e7. 2016
  • ORBIS telemedicine users..  119:880-881. 2012
  • Keratoconus..  116:2036-2037. 2009
  • DSEK in eyes with double glaucoma tubes..  115:1435-1435.e1. 2008
  • Six-week outcomes after pegaptanib..  113:501. 2006
  • Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity: A Multicenter Study. 2022
  • Reduced Mammography Screening for Breast Cancer among Women with Visual Impairment. 2021
  • HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. 2021
  • Visual Field Outcomes in the Tube Versus Trabeculectomy Study. 2020
  • Cost-Utility Analysis of Glaucoma Medication Adherence. 2020
  • Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial. 2020
  • Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials. 2019
  • Accuracy of Diagnostic Imaging Modalities for Classifying Pediatric Eyes as Papilledema Versus Pseudopapilledema. 2017
  • Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration. 2017
  • Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies. 2016
  • Association between Intraocular Pressure and Rates of Retinal Nerve Fiber Layer Loss Measured by Optical Coherence Tomography. 2016
  • Building a Culture of Safety in Ophthalmology. 2016
  • Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2. 2015
  • Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. 2007